Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.
Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (9)
- Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats 2026-10-01 · Expand citations
- A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults 2026-09-21 · Expand citations
- Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review 2026-07-01 · Expand citations
- Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex 2026-06-01 · Expand citations
- Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review 2026-03-09 · Expand citations
- Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans 2025-04-21 · Expand citations
- In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin 2024-01-08 · Expand citations
- Managing expectations with psychedelic microdosing 2023-11-08 · Expand citations
- Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats 2022-06-01 · Expand citations